top of page
daniel-price-mCGZPYjfROM-unsplash.jpg


Novapep is developing its biparetide peptide which is anti-inflammatory and cytoprotective to treat inflammatory bowel disease
and sepsis

Picture2.jpg

The Company

Novapep is a biotech company whose scientists invented the Biparetide agonist peptide structure, which mimics the mechanisms of Activated Protein C ('APC').  Novapep is  developing Biparetide for the treatment of inflammatory bowel disease and sepsis

b-4.jpg

IBD Program

In animal studies, APC has been shown to be an effective treatment of inflammatory bowel disease.  Novapep is developing oral and subq systemic peptide structures which are anti-inflammatory, protect against cell death and provide epithelial barrier protection  


Sepsis Program

image.png

Based on highly promising preclinical data for Biperatide in sepsis Novapep is developing intravenous Biparetide  for the treatment of sepsis which is anti-inflammatory, protects against cell death and provides endothelial barrier protection    

bottom of page